---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-039019"
form_type: "8-K"
ticker: "ANGO"
cik: "0001275187"
company_name: "ANGIODYNAMICS INC"
filed_at: "2026-10-08T11:16:17+00:00"
generated_at: "2026-10-12T15:38:25.552592+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.62
calibrated_materiality_score: 0.62
confidence: "high"
source: SEC EDGAR
---

# AngioDynamics names Eric Honroth President & CEO effective Nov 2, 2026; Jim Clemmer retires after 10 years

## Summary
- Honroth, 55, joins as President, CEO and board member on Nov 2, 2026, succeeding Jim Clemmer, who departs the board that day and stays on as a consultant.
- Honroth was Global President, Life Science at Getinge and previously ran Getinge's $1.2B North American business; earlier roles at Abbott Vascular, Becton Dickinson, CareFusion, Boston Scientific.
- Pay package: $735,000 base salary, 95% bonus target, $1,487,116 long-term incentive award, $450,000 RSU replacement grant, $350,000 sign-on bonus, $10,000/month commuting stipend.
- Severance: 18 months base salary and 18 months health coverage if terminated without cause; a Change in Control triggers 24 months salary, lump-sum target bonus and full equity vesting.
- Clemmer consulting fee is $30,000/month to Nov 2, 2027; retention pacts with all named executives except Clemmer accelerate RSUs and pro-rate PSUs. Director Howard Donnelly to retire at term end.

## SEC filing metadata
- accession: 0001140361-26-039019
- form_type: 8-K
- ticker: ANGO
- cik: 0001275187
- company_name: ANGIODYNAMICS INC
- filed_at: 2026-10-08T11:16:17+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.62
- calibrated_materiality_score: 0.62
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/0001140361-26-039019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/ef20083270_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-039019
- JSON: https://secwatch.observer/filing/0001140361-26-039019.json
- Plain text: https://secwatch.observer/filing/0001140361-26-039019.txt

## Key facts
- Executive change
  Eric Honroth was appointed as President and Chief Executive Officer at ANGIODYNAMICS INC.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On October 2, 2026, the Board of Directors of the Company (the “ Board ”) appointed Eric Honroth to serve as President and Chief Executive Officer of the Company, effective as of November 2, 2026 (the “ Effective Date ”) and concurrently with Mr. Clemmer’s retirement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/0001140361-26-039019-index.htm
- Executive change
  James C. Clemmer retired as Director at ANGIODYNAMICS INC.
  - Action: retired
  - Role: Director
  source text: Mr. Clemmer has served as a member of the Board since 2016 and his decision to retire was not the result of any disagreement between Mr. Clemmer and the Company on any matter relating to the Company’s operations, polices or practices.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/0001140361-26-039019-index.htm
- Executive change
  James C. Clemmer retired as President and Chief Executive Officer at ANGIODYNAMICS INC.
  - Action: retired
  - Role: President and Chief Executive Officer
  source text: As previously disclosed, James C. Clemmer has announced his intention to retire from his position as the President and Chief Executive Officer of the Company on the earlier of November 30, 2026 and appointment of a successor Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/0001140361-26-039019-index.htm
- Executive change
  Eric Honroth was appointed as Director at ANGIODYNAMICS INC.
  - Action: appointed
  - Role: Director
  source text: In addition, Mr. Honroth was appointed as a director on the Company’s Board as of the Effective Date, conditioned upon his commencement of service as President and Chief Executive Officer and concurrently with Mr. Clemmer’s retirement from his position as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/0001140361-26-039019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.